Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 191
Endocrine and Metabolic Disorders Drugs 162
Gastrointestinal Drugs 147
Immune Disorders Drugs 129
Central Nervous System Drugs 127
Biopharmaceuticals 87
Pharmaceuticals 82
Hematological Drugs 78
Vaccines 78
Clinical Trials 70
Drug Discovery 64
Cardiovascular Drugs 60
Diabetes Drugs 56
Infectious Diseases Drugs 56
Leukemia Drugs 52
Mental Disorders Drugs 46
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 41
Infusions and Injectables 33
Liver and Kidney Disorders Drugs 32
Over the Counter (OTC) Drugs 30
Lung Cancer Drugs 23
Pharmaceutical Manufacturing 20
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 19
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Schizophrenia Drugs 12
Prostate Cancer Drugs 11
Skin Cancer Drugs 11
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Thyroid Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Transdermal and Transmucosal Drug Delivery 5
Uterine Cancer Drugs 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Cough and Cold Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,646 Results (Page 31 of 83)
- Relevance
  Sort by

MTORC1 Protein Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

Fabry Disease Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

 Report
June 2023
115 Pages
Global

From

€3943EUR$4,500USD£3,402GBP

Next-Generation Antibody Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
110 Pages
Global

From

€4162EUR$4,750USD£3,591GBP

North America Intravenous Immunoglobulin Market Size and Forecasts 2020-2030, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, Distribution Channel, End User, and Country

 Report
October 2023
107 Pages
North America

From

€3023EUR$3,450USD£2,608GBP

Anti-CD38 antibody - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Peptide Therapeutics Market - Growth, Trends, COVID-19 Impact and Forecasts (2023-2028)

 Report
April 2023
107 Pages
Global

From

€4162EUR$4,750USD£3,591GBP

Eosinophilic Esophagitis (EoE): Opportunity Assessment and Forecast - Update

 Report
August 2025
66 Pages
Global

From

€15766EUR$17,995USD£13,605GBP

Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2025

 Clinical Trials
July 2025
195 Pages
Global

From

€3023EUR$3,450USD£2,608GBP

Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
700 Pages
Global

From

€2190EUR$2,500USD£1,890GBP

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

 Report
November 2023
63 Pages
Global

€8395EUR$9,918USD£7,000GBP

Anti-CD30 Therapies - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

Alzheimer's Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

 Drug Pipelines
May 2023
151 Pages
Global

From

€13137EUR$14,995USD£11,337GBP

Alzheimer's Disease Drugs - Global Strategic Business Report

 Report
February 2026
189 Pages
Global

From

€5125EUR$5,850USD£4,423GBP

Friedreich Ataxia - Global Clinical Trials Review, 2025

 Clinical Trials
January 2025
108 Pages
Global

From

€3023EUR$3,450USD£2,608GBP

Proteasome Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

 Report
April 2025
90 Pages
Global

From

€3500EUR$4,279USD£3,126GBP

Aurora-A Kinase Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2190EUR$2,500USD£1,890GBP

Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
295 Pages
Global

From

€2190EUR$2,500USD£1,890GBP

BRAFV600 Mutation (B-Raf Proto-oncogene, Serine/threonine Kinase) Inhibiotors - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

1,646 Results (Page 31 of 83)
- 1
- 29
- 30
- 31
- 32
- 33

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.